We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




First Multicenter Trial Confirms Effectiveness of Combined CT Angiography and Myocardial Perfusion Imaging Using 320-Detector Row CT

By HospiMedica International staff writers
Posted on 19 Sep 2012
Combined noninvasive computed tomography coronary angiography (CTA) and myocardial perfusion (CTP) with 320-detector row CT allows accurate identification of flow-limiting lesions requiring revascularization. More...
These are the key findings of the first worldwide multicenter trial evaluating the diagnostic performance of combined CTA and CTP as compared to the conventional evaluation of flow-limiting stenosis by means of single photon emission computed tomography-myocardial perfusion imaging (SPECT-MPI) and invasive coronary angiography (ICA).

The trial’s findings, CORE320, sponsored by Toshiba Medical Systems Corp. (Tokyo, Japan), were presented in Munich (Germany) August 25-29, 2012, during an European Society of Cardiology (ESC) Hotline Session by Dr. João A. C. Lima, MD, senior author of the study and professor of medicine and radiology at the Johns Hopkins University School of Medicine (Baltimore, MD, USA).

“The CORE 320 study is the first prospective, multicenter study to examine the diagnostic accuracy of CT for assessing blockages in blood vessels and determining which of those blockages may be preventing the heart from getting adequate blood flow. We found an excellent correlation in results when we compared the 320-detector CT testing with the traditional means of assessment using a stress test with imaging and cardiac catheterization” said Dr. Lima.

Three hundred eighty-one patients completed all imaging and were included in the primary analysis. The patient-based diagnostic accuracy (AUC) of combined CTA and CTP for detecting or excluding flow-limiting cornary artery disease (CAD) without history of CAD was 0.93 when the ICA stenosis reference standard was 50%. CTP increased the diagnostic accuracy of CTA alone to delineate flow-limiting disease (AUC: 0.87 vs. 0.81, respectively, p < 0.001). The combination of CTA and CTP had similar diagnostic power to the combination of ICA and SPECT-MPI in identifying revascularized patients at 30 days.

The researchers say the two modalities combined--CTA and CTP--still generate less radiation than a cardiac scan with the 64-slice CT scanner in widespread use today. Dr. Lima stated, “In our study, the amount of radiation exposure to patients from the two 320-slice CT scanner tests was half the amount they received as a result of the traditional evaluation methods--the angiogram and nuclear medicine stress test combined.”

The unique ability of Aquilion One, the dynamic volume CT system used in CORE320, which acquires the entire heart in a single temporally uniform volume, permits accurate myocardial perfusion analysis. The perfusion technique developed for Aquilion One provides perfusion images at the lowest possible radiation dose when AIDR (adaptive iterative dose reduction three-dimensional [3D]) reconstruction, is applied.

“One of Toshiba’s core missions is to validate its technology through clinical trials by leaders in the medical field,” explained Satoshi Tsunakawa, president of Toshiba Medical Systems Corp. “CORE320 has shown that it is now possible to perform a comprehensive cardiac functional and morphological analysis in just one, low-dose examination using Aquilion One. This technology can reduce the need to perform multiple examinations using different modalities, a true economical advantage and valuable contribution in cardiac healthcare,” said Mr. Tsunakawa.

The Aquilion Onesystem, in conjunction with myocardial perfusion software available on the VitreafX and Vitrea Enterprise Suite, includes all the features used for CORE 320 data acquisition and analysis, allowing physicians to perform myocardial perfusion imaging in their institution today.

“Training is another essential part of Toshiba’s myocardial perfusion solution,” said Tsunakawa. To assist physicians in implementing myocardial perfusion into their clinical practice, Toshiba is sponsoring the Myocardial Perfusion CT Workshops held at Rigshospitalet in Copenhagen (Denmark). Dr Klaus Kofoed, the co-program director, participated in CORE320 and brings a wealth of experience from the trial to all attendees.

Related Links:

Toshiba Medical Systems
Johns Hopkins University School of Medicine



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.